The anti-gastric cancer activity of anti-MUC1 and rosmarinic acid is reflected in the inhibition of mRNA expression of enzymes that produce cancer-associated antigens and specific antigens; the promotion of BAX, Bad and Caspase-3 and -9; and inhibition of Bcl-2 expression [70]. Here, BCL2 is linked to gastric cancer.